Allist Pharmaceuticals, Inc.
Clinical trials sponsored by Allist Pharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill hopes to shrink lung tumors in early trial Results expected Dec 2026 (estimated)
- Can a targeted pill keep lung cancer from returning? Results expected Dec 2026 (estimated)
- New targeted pill shows promise for Hard-to-Treat pancreatic cancer Results expected Dec 2026 (estimated)
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers? Results expected Mar 2027 (estimated)
- Can a targeted pill outsmart a tough lung cancer mutation? Results expected Aug 2027 (estimated)